EUVIMEDObjevte EUVIMED
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen access · CC BY 4.0

Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease

Mushood Ahmed, Areeba Ahsan, Aimen Shafiq, Raheel Ahmed, Mahboob Alam, Pierre Sabouret, Jamal S Rana, Gregg C Fonarow

Clinical Cardiology · 2024-10 · 47 (10)

DOI: 10.1002/clc.70026 ↗

At a glance

Vergleichsstudie in Clinical Cardiology, published online on 2024-10-07. Written by Mushood Ahmed and 7 co-authors. Institution: Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. Major MEDLINE topics: Anticoagulants, Atrial Fibrillation, Coronary Artery Disease, Fibrinolytic Agents. Cited 20 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: The authors received no specific funding for this work..

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Oral anticoagulants (OACs) are routinely used for the management of atrial fibrillation (AF) while antiplatelet agents are used in coronary artery disease (CAD). However, data regarding the comparative clinical outcomes of OAC monotherapy versus dual antithrombotic therapy (anticoagulant plus antiplatelet agent) in patients with AF and stable CAD are limited.

Methods

A comprehensive search of major databases including PubMed/MEDLINE, Cochrane Library, and Embase was performed from inception to September 1, 2024 to identify randomized control trials (RCTs) that compared OAC monotherapy with dual antithrombotic therapy in patients with AF and stable CAD. The risk ratios (RRs) were estimated with corresponding 95% confidence intervals (CIs) for all outcomes.

Results

A total of three RCTs reported data for 3945 patients with AF and stable CAD. The mean age of patients was 73.8 (±11.85) years and the mean follow‐up was 22 months. OAC monotherapy was associated with a significantly reduced relative risk of major bleeding (RR: 0.55, 95% CI: 0.32–0.95) compared to dual therapy. The risk of all‐cause death (RR: 0.85, 95% CI: 0.49–1.48), cardiovascular death (RR: 0.84, 95% CI: 0.50–1.41), any stroke event (RR: 0.74, 95% CI: 0.46–1.18), and myocardial infarction (RR: 1.57, 95% CI: 0.79–3.12) remained comparable across the two groups.

Conclusion

OAC monotherapy led to a significant relative risk reduction for major bleeding with similar rates of ischemic events and mortality compared to dual antithrombotic therapy in patients with AF and stable CAD.

Subjects

MeSH terms (MEDLINE)

AnticoagulantsAtrial FibrillationCoronary Artery DiseaseFibrinolytic AgentsHumansAdministration, OralDrug Therapy, CombinationHemorrhagePlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicTreatment Outcome

Author keywords

anticoagulantantiplateletatrial fibrillationcoronary artery disease

Substances

AnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Authors and institutions

  • Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • Department of Medicine, Foundation University Medical College, Islamabad, Pakistan.
  • Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Department of Cardiology, Royal Brompton Hospital, London, UK.
  • Department of Cardiology, National Heart and Lung Institute, Imperial College, London, UK.
  • Department of Cardiology, Baylor College of Medicine, Houston, Texas, USA.

Funding

  • The authors received no specific funding for this work.

Cite

APA

Ahmed, M., Ahsan, A., Shafiq, A., Ahmed, R., Alam, M., Sabouret, P., Rana, J. S., & Fonarow, G. C. (2024). Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clinical Cardiology, 47(10). https://doi.org/10.1002/clc.70026

Vancouver

Ahmed M, Ahsan A, Shafiq A, Ahmed R, Alam M, Sabouret P, et al. Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clinical Cardiology. 2024;47(10). doi:10.1002/clc.70026

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Mushood and Ahsan, Areeba and Shafiq, Aimen and Ahmed, Raheel and Alam, Mahboob and Sabouret, Pierre and Rana, Jamal S and Fonarow, Gregg C},
  title = {Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease},
  journal = {Clinical Cardiology},
  year = {2024},
  volume = {47},
  number = {10},
  doi = {10.1002/clc.70026}
}
Start for free →